What treatments are available for non-arteritic ischaemic optic neuropathy, and how can vision loss be mitigated?

No direct evidence for effective treatments to improve vision loss in non-arteritic ischemic optic neuropathy was identified. While glucocorticoids, neuroprotective agents, and surgical options have been explored, their efficacy remains uncertain, highlighting the need for further research.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-16
DOI
https://doi.org/10.5281/zenodo.24281819
Primary Topic
Glaucoma and retinal disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

What treatments are available for non-arteritic ischaemic optic neuropathy, and how can vision loss be mitigated?

Tripdatabase
Zenodo (CERN European Organization for Nuclear Research)
Glaucoma and retinal disorders
article

What treatments are available for non-arteritic ischaemic optic neuropathy, and how can vision loss be mitigated?

Tripdatabase
article en

Abstract

No direct evidence for effective treatments to improve vision loss in non-arteritic ischemic optic neuropathy was identified. While glucocorticoids, neuroprotective agents, and surgical options have been explored, their efficacy remains uncertain, highlighting the need for further research.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Glaucoma and retinal disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon